PFS Partners’s cbdMD YCBD Stock Holding History

PFS Partners’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13	Closed	-$4.68K	–	366
2022 Q1	$4.68K	Buy	13 +7	+117%	+$2.36K	﹤0.01%	261
2021 Q4	$2.16K	Buy	+6	New	+$3.49K	﹤0.01%	308

Other funds holding YCBD

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CIM

Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return

PFS Partners's YCBD Position: Q2 2022 in Review

PFS Partners sold out of cbdMD (YCBD) in Q2 2022, closing a stake of 13 shares — an estimated $4.68K sold.

PFS Partners first reported a position in YCBD in Q4 2021 and held it in 2 quarters. The position peaked at $4.68K in Q1 2022. 51 funds tracked by Wall St. Rank hold YCBD as of Q2 2022.

PFS Partners reported no remaining cbdMD position as of Q2 2022 after selling out during the quarter.
PFS Partners sold 13 cbdMD shares in Q2 2022, an estimated $4.68K.
PFS Partners first reported a position in cbdMD in Q4 2021 and held it in 2 quarters.
PFS Partners's cbdMD position peaked at $4.68K in Q1 2022.
51 funds tracked by Wall St. Rank held cbdMD as of Q2 2022.

Based on PFS Partners's 13F filing for Q2 2022, filed 1 Dec 2023.